{"schema_version":"secwatch.filing_event.v1","accession":"0000072331-24-000169","form_type":"8-K","ticker":"NDSN","cik":"0000072331","company_name":"NORDSON CORP","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.913738+00:00","generated_at":"2026-05-29T04:54:56.547283+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nordson reports Q4 sales up 4% to $744M; FY2024 record sales $2.7B; guides FY2025 adjusted EPS $9.70-$10.50","bullets":["Q4 GAAP EPS $2.12 (down from $2.22 YoY); adjusted EPS $2.78 (up from $2.71 YoY).","Full-year adjusted EPS $9.73 (down from $9.85); EBITDA record $849M (32% of sales).","Organic sales fell 3% in Q4; Industrial Precision Solutions segment down 3% YoY.","Atrion Medical acquisition contributed to Medical & Fluid Solutions segment sales +19%.","Fiscal 2025 guidance: sales $2.75-$2.87B; Q1 adjusted EPS $1.95-$2.15 on seasonally weak quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0000072331-24-000169","json":"https://secwatch.observer/filing/0000072331-24-000169.json","markdown":"https://secwatch.observer/filing/0000072331-24-000169.md","text":"https://secwatch.observer/filing/0000072331-24-000169.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72331/000007233124000169/0000072331-24-000169-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72331/000007233124000169/ndsn-20241211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:54:56.547283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}